The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Interleukin‐6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus
Abstract
Objective: To define the cytokine and chemokine profile in cerebrospinal fluid (CSF) from patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Methods: Forty‐two SLE patients who had been hospitalized because of NP manifestations were studied. Patients were evaluated at hospitalization and 6 months later; a CSF sample was obtained at each evaluation. As controls, CSF from 6 SLE patients with septic meningitis, 16 SLE patients with no history of NP manifestations (non‐NPSLE), and 25 patients with nonautoimmune diseases were also studied. Soluble molecules, including cytokines (interleukin‐2 [IL‐2], IL‐4, IL‐6, IL‐10, tumor necrosis factor α [TNFα], and interferon‐γ [IFNγ]) and chemokines (monocyte chemotactic protein 1 [MCP‐1], RANTES, IL‐8, monokine induced by IFNγ [MIG], and interferon‐γ–inducible 10‐kd protein [IP‐10]), were measured with the use of cytometric bead array kits. Results: CSF levels of the following molecules were significantly increased in NPSLE patients as compared with non‐NPSLE and nonautoimmune diseases control patients, respectively: IL‐6 (32.7 versus 3.0 and 2.96 pg/ml), IL‐8 (102.8 versus 29.97 and 19.7 pg/ml), IP‐10 (888.2 versus 329.7 [P not significant] and 133.6 pg/ml), RANTES (3.8 versus 2.5 and 2.2 pg/ml), MCP‐1 (401.7 versus 257.9 [P not significant] and 136.9 pg/ml), and MIG (35.4 versus 11.4 and 3.5 pg/ml). Low levels of IL‐2, IL‐4, IL‐10, TNFα, and IFNγ were found in all groups. All cytokines and chemokines, except TNFα, were significantly higher among the SLE patients with septic meningitis than among the NPSLE patients. Six months later and in the absence of NP manifestations, all elevated molecule levels, except RANTES, in patients with NPSLE had decreased significantly, and no differences were noted between the NPSLE and non‐NPSLE groups. Conclusion: A central nervous system response composed of IL‐6 and chemokines, but not Th1/Th2 cytokines, is associated with NP manifestations in SLE patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease
Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Bouwman, F., Venturelli, E., Guidi, I., Blankenstein, M. A., Bresolin, N., & Scarpini, E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.538 · Cited by 289
Cited by
Bertsias, G. K., Ioannidis, J. P. A., Aringer, M., Bollen, E., Bombardieri, S., Bruce, I. N., Cervera, R., Dalakas, M., Doria, A., Hanly, J. G., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.130476 · Cited by 742
Chemokine (C–X–C motif) ligand (CXCL)10 in autoimmune diseases
Antonelli, A., Ferrari, S. M., Giuggioli, D., Ferrannini, E., Ferri, C., & Fallahi, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.010 · Cited by 595
Neuropsychiatric lupus: new mechanistic insights and future treatment directions
Schwartz, N., Stock, A. D., & Putterman, C. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0156-8 · Cited by 429
CXCL10 and autoimmune diseases
Lee, E. Y., Lee, Z.-H., & Song, Y. W. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.12.002 · Cited by 357
Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers
Jeltsch-David, H., & Muller, S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.148 · Cited by 304
Metadata
- Authors
- Fragoso‐Loyo, H., Richaud‐Patin, Y., Orozco‐Narváez, A., Dávila‐Maldonado, L., Atisha‐Fregoso, Y., Llorente, L., & Sánchez‐Guerrero, J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2007-03-28
- Volume
- 56
- Issue
- 4
- Pages
- 1242-1250
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2054064642
- Cited by
- 184
- References
- 1
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.